In IgA nephropathy patients, urinary kininogen excretion was found significantly different for responders and non-responders to an angiotensin-converting-enzyme inhibitor (ACE-inhibitor) therapy27, which may be in alignment with the reported variants of kininogen gene influencing individual response to aldosterone28. The gene discussed is ACE; the disease is IgA glomerulonephritis.